FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to pharmaceutics and medicine and concerns a pharmaceutical combination for treating or delaying the progression or onset of diabetes, containing a compound which is an SGLT2 inhibitor of formula
,
and at least one of an antidiabetic drug other than the SGLT2 inhibitor for treating obesity, and/or an anitihypertensive drug.
EFFECT: what is presented is a new pharmaceutical combination for treating or delaying the progression or onset of diabetes.
18 cl, 16 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS FOR SGLT2 INHIBITOR OBTAINING AND APPLICATION | 2013 |
|
RU2643764C2 |
| C-ARYL GLUCOSIDE SGLT2 INHIBITORS AND METHOD OF THEIR APPLICATION | 2003 |
|
RU2337916C2 |
| C-ARYL GLUCOSE SGLT2 INHIBITORS AND METHOD OF THEIR USE | 2020 |
|
RU2800510C1 |
| C-ARYL GLUCOSIDE SGLT2 INHIBITORS AND METHOD OF THEIR USE | 2020 |
|
RU2746132C1 |
| O-ARYLGLUCOSIDE INHIBITORS OF SGLT2 AND METHOD FOR THEIR USING | 2001 |
|
RU2269540C2 |
| C-ARYLGLUCOSIDE INHIBITORS OF SGLT-2 | 2000 |
|
RU2262507C2 |
| COMPOSITIONS OF PILL WITH IMMEDIATE RELEASE | 2010 |
|
RU2558798C2 |
| TWO-LAYER TABLET COMPOSITION | 2020 |
|
RU2824129C2 |
| DOUBLE-LAYER TABLET COMPOSITION | 2010 |
|
RU2712757C2 |
| BI-LAYER TABLET COMPOSITION | 2010 |
|
RU2583920C2 |
